These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 16696161)

  • 1. COL-3 benefits patients with AIDS-related Kaposi's sarcoma.
    Furlow B
    Lancet Oncol; 2006 May; 7(5):368. PubMed ID: 16696161
    [No Abstract]   [Full Text] [Related]  

  • 2. Randomized phase II trial of matrix metalloproteinase inhibitor COL-3 in AIDS-related Kaposi's sarcoma: an AIDS Malignancy Consortium Study.
    Dezube BJ; Krown SE; Lee JY; Bauer KS; Aboulafia DM
    J Clin Oncol; 2006 Mar; 24(9):1389-94. PubMed ID: 16549833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinase inhibitor COL-3 in the treatment of AIDS-related Kaposi's sarcoma: a phase I AIDS malignancy consortium study.
    Cianfrocca M; Cooley TP; Lee JY; Rudek MA; Scadden DT; Ratner L; Pluda JM; Figg WD; Krown SE; Dezube BJ
    J Clin Oncol; 2002 Jan; 20(1):153-9. PubMed ID: 11773164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment update for AIDS-related Kaposi's sarcoma.
    Mihalcea AM; Smith DL; Monini P; Sgadari C; Ensoli B; Gill PS
    AIDS; 1999; 13 Suppl A():S215-25. PubMed ID: 10885778
    [No Abstract]   [Full Text] [Related]  

  • 5. Acquired immunodeficiency syndrome (AIDS) and Kaposi's sarcoma.
    Martin J
    Int J Dermatol; 1984 Sep; 23(7):483-6. PubMed ID: 6386714
    [No Abstract]   [Full Text] [Related]  

  • 6. Psoriasiform pustular eruptions from pegylated-liposomal doxorubicin in AIDS-related Kaposi's sarcoma.
    Kreuter A; Gambichler T; Schlottmann R; Altmeyer P; Brockmeyer N
    Acta Derm Venereol; 2001; 81(3):224. PubMed ID: 11558892
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of early AIDS-related Kaposi's sarcoma with oral all-trans-retinoic acid: results of a sequential non-randomized phase II trial. Kaposi's Sarcoma ANRS Study Group. Agence Nationale de Recherches sur le SIDA.
    Saiag P; Pavlovic M; Clerici T; Feauveau V; Nicolas JC; Emile D; Chastang C
    AIDS; 1998 Nov; 12(16):2169-76. PubMed ID: 9833858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignancies in the AIDS patient: natural history, treatment strategies, and preliminary results.
    Longo DL; Steis RG; Lane HC; Lotze MT; Rosenberg SA; Preble O; Masur H; Rook AH; Fauci AS; Jacob J
    Ann N Y Acad Sci; 1984; 437():421-30. PubMed ID: 6598311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha interferon therapy of Kaposi's sarcoma in AIDS.
    Volberding P; Valero R; Rothman J; Gee G
    Ann N Y Acad Sci; 1984; 437():439-46. PubMed ID: 6398652
    [No Abstract]   [Full Text] [Related]  

  • 10. A phase II study of recombinant human interferon-alpha 2a and zidovudine in patients with AIDS-related Kaposi's sarcoma. AIDS Clinical Trials Group.
    Fischl MA; Finkelstein DM; He W; Powderly WG; Triozzi PL; Steigbigel RT
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Apr; 11(4):379-84. PubMed ID: 8601224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. All-trans retinoic acid for the treatment of AIDS-related Kaposi's sarcoma: results of a pilot phase II study.
    Gill PS; Espina BM; Moudgil T; Kidane S; Esplin JA; Tulpule A; Levine AM
    Leukemia; 1994; 8 Suppl 3():S26-32. PubMed ID: 7808021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant leukocyte A interferon in Kaposi's sarcoma.
    Krown SE; Real FX; Krim M; Cunningham-Rundles S; Koziner B; Myskowski PL; Safai B; Oettgen HF
    Ann N Y Acad Sci; 1984; 437():431-8. PubMed ID: 6398651
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of chemotherapy for epidemic Kaposi's sarcoma.
    Volberding PA
    Semin Oncol; 1987 Jun; 14(2 Suppl 3):23-6. PubMed ID: 2440109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AIDS-associated Kaposi's sarcoma.
    Kahn JO
    AIDS Clin Rev; 1990; ():115-28. PubMed ID: 1707293
    [No Abstract]   [Full Text] [Related]  

  • 15. Phase I study of human chorionic gonadotropin given subcutaneously to patients with acquired immunodeficiency syndrome-related mucocutaneous Kaposi's sarcoma.
    Gill PS; McLaughlin T; Espina BM; Tulpule A; Louie S; Lunardi-Iskandar Y; Gallo RC
    J Natl Cancer Inst; 1997 Dec; 89(23):1797-802. PubMed ID: 9392621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photodynamic therapy improves Kaposi's sarcoma in AIDS patients.
    Schweitzer VG
    Am Fam Physician; 1988 Nov; 38(5):260. PubMed ID: 3189128
    [No Abstract]   [Full Text] [Related]  

  • 17. Photofrin photodynamic therapy for treatment of AIDS-related cutaneous Kaposi's sarcoma.
    Bernstein ZP; Wilson BD; Oseroff AR; Jones CM; Dozier SE; Brooks JS; Cheney R; Foulke L; Mang TS; Bellnier DA; Dougherty TJ
    AIDS; 1999 Sep; 13(13):1697-704. PubMed ID: 10509571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II study of oral idarubicin in patients with AIDS-associated Kaposi's sarcoma.
    Chachoua A; Green M; Laubenstein L; Wernz J; Muggia FM
    Cancer Treat Rep; 1987; 71(7-8):775-6. PubMed ID: 3475172
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapy of Kaposi's sarcoma in AIDS.
    Volberding P
    Semin Oncol; 1984 Mar; 11(1):60-7. PubMed ID: 6372100
    [No Abstract]   [Full Text] [Related]  

  • 20. Failure (and danger) of mitozantrone in AIDS-related Kaposi's sarcoma.
    Kaplan L; Volberding PA
    Lancet; 1985 Aug; 2(8451):396. PubMed ID: 2862556
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.